Medifast, Inc.
New York Stock ExchangeTotal Valuation
Medifast, Inc. carries a market capitalization of 133.87M, placing it among publicly traded companies globally. Its enterprise value stands at -23.57M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 133.87M |
| Enterprise Value | -23.57M |
Share Statistics
Medifast, Inc. currently has 11.18M shares outstanding.
| Shares Outstanding | 11.18M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Medifast, Inc. trades at a trailing price-to-earnings ratio of 604.51. The price-to-sales ratio is 0.37, and the price-to-book ratio stands at 0.60.
| PE Ratio | 604.51 |
| PS Ratio | 0.37 |
| PB Ratio | 0.60 |
| P/TBV Ratio | 0.60 |
| P/FCF Ratio | 8.62 |
| P/OCF Ratio | 13.31 |
Financial Position
Medifast, Inc. maintains a current ratio of 4.86, meaning it holds 4.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.86 |
| Quick Ratio | 4.09 |
| Debt / Equity | 14.06 |
| Debt / EBITDA | -4.88 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -12.42 |
| Return on Assets (ROA) | -9.67 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.79 |
Taxes
| Income Tax | 11.63M |
| Effective Tax Rate | N/A |
Stock Price Statistics
Medifast, Inc.'s stock has declined approximately -13.81532% over the past 52 weeks. The 50-day moving average sits at 11.28, while the 200-day moving average is 11.20.
| Beta (5Y) | N/A |
| 52-Week Price Change | -13.81532% |
| 50-Day Moving Average | 11.28 |
| 200-Day Moving Average | 11.20 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Medifast, Inc. generated 316.93M in revenue and converted that into -25.60M in net income, yielding earnings per share of -2.32. EBITDA reached -5.66M, while operating income came in at -19.51M.
| Revenue | 316.93M |
| Gross Profit | 219.45M |
| Operating Income | -19.51M |
| Pretax Income | -13.97M |
| Net Income | -25.60M |
| EBITDA | -5.66M |
| EBIT | -19.51M |
| Earnings Per Share (EPS) | -2.32 |
Balance Sheet
Medifast, Inc. holds 169.82M in cash and equivalents against 27.62M in total debt, resulting in a net debt position of -71.91M. Total book value stands at 196.38M, with working capital of 160.47M providing operational flexibility.
| Cash & Cash Equivalents | 169.82M |
| Total Debt | 27.62M |
| Net Debt | -71.91M |
| Equity (Book Value) | 196.38M |
| Book Value Per Share | 17.56 |
| Working Capital | 160.47M |
Cash Flow
Medifast, Inc. produced 8.79M in operating cash flow over the past twelve months. After subtracting -4.78M in capital expenditures, free cash flow totaled 4.01M - equivalent to 0.36 per share.
| Operating Cash Flow | 8.79M |
| Capital Expenditures | -4.78M |
| Free Cash Flow | 4.01M |
| FCF Per Share | 0.36 |
Margins
Medifast, Inc. operates with a gross margin of 69.24, reflecting its pricing power and cost economics. The operating margin of -6.15 and net profit margin of -8.08 provide insight into operational efficiency.
| Gross Margin | 69.24 |
| Operating Margin | -6.15 |
| Pretax Margin | -4.41 |
| Profit Margin | -8.08 |
| EBITDA Margin | -1.79 |
Dividends & Yields
The company's payout ratio of -0.66 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.02 |
| Dividend Yield | N/A |
| Payout Ratio | -0.66 |
| Shareholder Yield | 0.83 |
| FCF Yield | 11.60 |
Scores
Medifast, Inc. posts an Altman Z-Score of 3.64, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.64 |